{
    "nctId": "NCT01795612",
    "briefTitle": "Adapted Physical Activity Effect on Aerobic Function and Fatigue at Home in Patients With Breast Cancer Treated in Adjuvant or Neoadjuvant Phase",
    "officialTitle": "Adapted Physical Activity Effect on Aerobic Function and Fatigue at Home in Patients With Breast Cancer Treated in Adjuvant or Neoadjuvant Phase",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 94,
    "primaryOutcomeMeasure": "The main criterion is exercise tolerance at 12 months measured by VO2peak by incremental cardiopulmonary exercise test",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* females between 18 and 75 years of age;\n* signed written informed consent;\n* willing to take part in the trial and to follow the instructions;\n* breast tumour, histologically documented;\n* patients for whom a 6-treatment course of adjuvant or neoadjuvant chemotherapy (3FEC100 +3 taxanes or 6 FEC) +/- radiotherapy+/- Herceptin has been scheduled;\n\nExclusion Criteria:\n\n* metastatic cancer;\n* disability preventing a proper understanding of the instructions for the trial;\n* patients who are subject to a court protection, wardship or guardianship order;\n* uncontrolled hypertension;\n* family history of sudden death in a first-degree relative;\n* unstabilised heart disease;\n* current treatment with beta-blockers;\n* chronic or acute pulmonary disease associated with dyspnoea upon moderate effort;\n* uncontrolled thyroid dysfunction;\n* uncontrolled diabetes;\n* any other serious conditions that are unstabilised,\n* disabling or in which physical exercise is contra-indicated;\n* unable to attend for follow-up throughout the duration of the study;\n* ventricular ejection fraction (VEF) \\< 50%, pregnancy or suckling.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}